Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) Receivables - Net (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Receivables - Net for 13 consecutive years, with $1.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Receivables - Net changed N/A to $1.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $1.0 million, a N/A change, with the full-year FY2024 number at $600000.0, changed N/A from a year prior.
  • Receivables - Net was $1.0 million for Q2 2025 at Plus Therapeutics, up from $600000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $1.0 million in Q2 2025 to a low of $600000.0 in Q4 2024.